Media stories about Intuitive Surgical (NASDAQ:ISRG) have trended somewhat positive on Monday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intuitive Surgical earned a news sentiment score of 0.24 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 45.8189863109207 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- Intuitive Surgical (ISRG) Rating Increased to Strong-Buy at Vetr (americanbankingnews.com)
- World-leading robotic surgery machine ‘inspires’ Jackson students (mlive.com)
- Manual Surgical Stapler Market: Growth, Trends, Region and Forecast to 2022 (newspharmaceuticals.com)
- As use of robotic surgery increases, training and regulation become more rigorous (healio.com)
- Robots Could Replace Surgeons in the Battle Against Cancer (bloomberg.com)
ISRG has been the topic of a number of analyst reports. BidaskClub downgraded Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 12th. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 price target on the stock in a report on Tuesday, December 12th. Royal Bank of Canada lifted their price target on Intuitive Surgical to $430.00 and gave the company a “sector perform” rating in a report on Friday, January 26th. Canaccord Genuity reiterated a “hold” rating and issued a $410.00 price target (up from $380.00) on shares of Intuitive Surgical in a report on Friday, January 26th. They noted that the move was a valuation call. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $410.00 price target on shares of Intuitive Surgical in a report on Friday, January 5th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $413.84.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.27 by $0.27. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. The firm had revenue of $892.40 million for the quarter, compared to the consensus estimate of $866.54 million. During the same period in the previous year, the business earned $2.03 EPS. The firm’s revenue for the quarter was up 17.9% on a year-over-year basis. research analysts predict that Intuitive Surgical will post 7.85 EPS for the current fiscal year.
In other Intuitive Surgical news, CFO Marshall Mohr sold 7,500 shares of Intuitive Surgical stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $414.19, for a total transaction of $3,106,425.00. Following the completion of the sale, the chief financial officer now owns 13,816 shares of the company’s stock, valued at approximately $5,722,449.04. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Gary S. Guthart sold 28,525 shares of Intuitive Surgical stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $414.50, for a total value of $11,823,612.50. Following the sale, the chief executive officer now directly owns 311,469 shares of the company’s stock, valued at approximately $129,103,900.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 102,770 shares of company stock worth $43,410,836. 2.20% of the stock is owned by company insiders.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.